• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重复推注心房利钠肽对肝硬化难治性腹水患者的影响。

Effects of repeated atrial natriuretic peptide bolus injections in cirrhotic patients with refractory ascites.

作者信息

Laffi G, Marra F, Pinzani M, Meacci E, Tosti-Guerra C, De Feo M L, Gentilini P

机构信息

Istituto di Clinica Medica II, University of Florence School of Medicine, Italy.

出版信息

Liver. 1989 Dec;9(6):315-21. doi: 10.1111/j.1600-0676.1989.tb00418.x.

DOI:10.1111/j.1600-0676.1989.tb00418.x
PMID:2532698
Abstract

The renal and hormonal effects of repeated atrial natriuretic peptide (ANP) boli (1 microgram/kg of body weight) were studied in eight cirrhotic patients with refractory ascites. Under basal conditions the patients showed a striking activation of the renin-angiotensin-aldosterone system (plasma renin activity 19.3 +/- 3.0 ng/ml.h, plasma aldosterone concentration 3.87 +/- 0.58 ng/ml) and a tenfold elevation in plasma ANP levels compared to healthy subjects (131.7, range 47.0-288.6, vs. 9.8, range 5.0-15.0, fmol/ml, p less than 0.001). The first ANP injection was followed by a remarkable increase in plasma ANP levels and by a slight increase in urinary cyclic guanosine-monophosphate excretion (from 1050.8 +/- 454.8 to 1446.6 +/- 822.2 pmol/min). A significant reduction of mean blood pressure (MBP) occurred 5 min after the first injection (from 86.7 +/- 7.2 to 79.9 +/- 5.8 mmHg, p less than 0.05), but values gradually returned to the baseline after 30 min. Heart rate (HR) increased 10 min after the first bolus injection (from 83.75 +/- 4.7 to 88.1 +/- 4.6 beats/min) and reached baseline values after 30 min. Similar behaviour of MBP and HR was observed after the second, third and fourth bolus injections. Urinary sodium excretion, urinary flow, glomerular filtration rate, plasma renin activity, and plasma aldosterone concentration did not show any significant modification during ANP administration, nor did these parameters change in the following 12-h recovery period.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对8例顽固性腹水肝硬化患者进行了反复静脉注射心房利钠肽(ANP,1微克/千克体重)的肾脏及激素效应研究。在基础状态下,患者的肾素 - 血管紧张素 - 醛固酮系统显著激活(血浆肾素活性为19.3±3.0纳克/毫升·小时,血浆醛固酮浓度为3.87±0.58纳克/毫升),与健康受试者相比,血浆ANP水平升高了10倍(分别为131.7,范围47.0 - 288.6,与9.8,范围5.0 - 15.0飞摩尔/毫升,p<0.001)。首次注射ANP后,血浆ANP水平显著升高,尿中环磷酸鸟苷排泄略有增加(从1050.8±454.8增至1446.6±822.2皮摩尔/分钟)。首次注射后5分钟平均血压(MBP)显著降低(从86.7±7.2降至79.9±5.8毫米汞柱,p<0.05),但30分钟后逐渐恢复至基线水平。首次推注后10分钟心率(HR)增加(从83.75±4.7增至88.1±4.6次/分钟),30分钟后恢复至基线值。第二次、第三次和第四次推注后观察到MBP和HR有类似表现。在ANP给药期间,尿钠排泄、尿流量、肾小球滤过率、血浆肾素活性和血浆醛固酮浓度均未显示出任何显著变化,在随后的12小时恢复期内这些参数也未改变。(摘要截选至250字)

相似文献

1
Effects of repeated atrial natriuretic peptide bolus injections in cirrhotic patients with refractory ascites.重复推注心房利钠肽对肝硬化难治性腹水患者的影响。
Liver. 1989 Dec;9(6):315-21. doi: 10.1111/j.1600-0676.1989.tb00418.x.
2
Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.高剂量心房利钠肽对有腹水和无腹水肝硬化患者肾脏血流动力学、钠代谢及激素的影响。
Scand J Clin Lab Invest. 1995 Jul;55(4):273-87. doi: 10.3109/00365519509104964.
3
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites.人心房利钠肽输注对肝硬化腹水患者肾血流动力学及利钠作用的影响
Gastroenterology. 1989 Jan;96(1):167-77. doi: 10.1016/0016-5085(89)90777-4.
4
Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.心房利钠肽在肾病综合征中利钠作用减弱:环磷酸鸟苷降低的潜在作用
Nephron. 1995;71(1):44-53. doi: 10.1159/000188673.
5
Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.低剂量心房利钠肽在代偿期肝硬化中的心血管和肾脏效应
Am J Gastroenterol. 1997 May;92(5):852-7.
6
Dose-response study of atrial natriuretic peptide bolus injection in healthy man.健康男性静脉注射心房利钠肽的剂量反应研究。
Eur J Clin Invest. 1993 Jan;23(1):37-45. doi: 10.1111/j.1365-2362.1993.tb00715.x.
7
Atrial natriuretic peptide administered as intravenous infusion or bolus injection to patients with liver cirrhosis and ascites.以静脉输注或大剂量注射方式给予肝硬化腹水患者心房利钠肽。
J Cardiovasc Pharmacol. 1988 Sep;12(3):279-85. doi: 10.1097/00005344-198809000-00004.
8
Effect of atrial natriuretic peptide (8-33-Met ANP) in patients with hypertension.
Am J Hypertens. 1992 May;5(5 Pt 1):266-75. doi: 10.1093/ajh/5.5.266.
9
Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites.肝硬化和顽固性腹水患者对心房利钠肽与特利加压素联合用药的利钠反应。
J Hepatol. 1997 Jun;26(6):1229-34. doi: 10.1016/s0168-8278(97)80456-4.
10
Plasma atrial natriuretic peptide and renin-aldosterone in patients with cirrhosis and ascites: basal levels, changes during daily activity and nocturnal diuresis.肝硬化腹水患者的血浆心房利钠肽及肾素 - 醛固酮:基础水平、日常活动期间的变化及夜间利尿情况
Hepatology. 1992 Jul;16(1):82-8. doi: 10.1002/hep.1840160115.

引用本文的文献

1
Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis.利钠肽治疗肝硬化腹水的疗效与安全性:一项系统评价和荟萃分析。
World J Hepatol. 2022 Apr 27;14(4):827-845. doi: 10.4254/wjh.v14.i4.827.
2
Natriuretic peptide receptors regulate endothelin synthesis and release from parathyroid cells.利钠肽受体调节甲状旁腺细胞中内皮素的合成与释放。
Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6496-500. doi: 10.1073/pnas.88.15.6496.